(Q95923717)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32460002%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

title

RAC1 as a Therapeutic Target in Malignant Melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32460002%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

Alexa C Cannon

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32460002%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Cristina Uribe-Alvarez

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32460002%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Jonathan Chernoff

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32460002%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

publication date

18 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32460002%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32460002%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32460002%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32460002%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

478-488

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32460002%20AND%20SRC:MED&resulttype=core&format=json

Rho-GTPases: new members, new pathways

31 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

The diverse roles of Rac signaling in tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Rho GTPases in cell biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

An essential role for Rac in Ras transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Acquired Resistance of EGFR-Mutated Lung Cancer to Tyrosine Kinase Inhibitor Treatment Promotes PARP Inhibitor Sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Rac signaling in breast cancer: a tale of GEFs and GAPs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Melanoma genome sequencing reveals frequent PREX2 mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

RAC1 inhibition as a therapeutic target for gefitinib-resistant non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

ERK/MAPK Signaling Drives Overexpression of the Rac-GEF, PREX1, in BRAF- and NRAS-Mutant Melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

PREX1 drives spontaneous bone dissemination of ER+ breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Phosphatidylinositol-3,4,5-Trisphosphate Dependent Rac Exchange Factor 1 (PREX1) is a Novel Predictor of Prognosis for Breast Cancer Patients: A Retrospective Case Series

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Truncating PREX2 mutations activate its GEF activity and alter gene expression regulation in NRAS-mutant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Enhanced Dendritic Actin Network Formation in Extended Lamellipodia Drives Proliferation in Growth-Challenged Rac1P29S Melanoma Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

The small GTP-binding protein rac regulates growth factor-induced membrane ruffling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of RAS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Requirement for Rac1 in a K-ras induced lung cancer in the mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Early requirement of Rac1 in a mouse model of pancreatic cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Rac1 is crucial for Ras-dependent skin tumor formation by controlling Pak1-Mek-Erk hyperactivation and hyperproliferation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Rac1 is a novel therapeutic target in mantle cell lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Overexpression of Rac1 in leukemia patients and its role in leukemia cell migration and growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Activation of Rac1 GTPase promotes leukemia cell chemotherapy resistance, quiescence and niche interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

RAC1P29S is a spontaneously activating cancer-associated GTPase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Rho GTPases are over-expressed in human tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Phosphatidylinositol 3-Kinase α-Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Prognostic and Clinicopathological Value of Rac1 in Cancer Survival: Evidence from a Meta-Analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

The RAC1 P29S hotspot mutation in melanoma confers resistance to pharmacological inhibition of RAF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

FLT3-ITD cooperates with Rac1 to modulate the sensitivity of leukemic cells to chemotherapeutic agents via regulation of DNA repair pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

RAC1b Overexpression Confers Resistance to Chemotherapy Treatment in Colorectal Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Rac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

The Rac1 splice form Rac1b promotes K-ras-induced lung tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Expression of Rac1b stimulates NF-kappaB-mediated cell survival and G1/S progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

RAC1b overexpression stimulates proliferation and NF-kB-mediated anti-apoptotic signaling in thyroid cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Rac1b, a tumor associated, constitutively active Rac1 splice variant, promotes cellular transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Constitutive RAC activation is not sufficient to initiate melanocyte neoplasia but accelerates malignant progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

A landscape of driver mutations in melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Conformational resolution of nucleotide cycling and effector interactions for multiple small GTPases determined in parallel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

DOCK1 inhibition suppresses cancer cell invasion and macropinocytosis induced by self-activating Rac1P29S mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

RAC1P29S Induces a Mesenchymal Phenotypic Switch via Serum Response Factor to Promote Melanoma Development and Therapy Resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

RAC1 P29S regulates PD-L1 expression in melanoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Tissue-Specific Oncogenic Activity of KRASA146T

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Heterozygous activating mutation in RAC2 causes infantile-onset combined immunodeficiency with susceptibility to viral infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Cooperative activation of PI3K by Ras and Rho family small GTPases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

PAK signalling during the development and progression of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Suppression of RAC1-driven malignant melanoma by group A PAK inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

WAVE2 serves a functional partner of IRSp53 by regulating its interaction with Rac

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Actin' together: serum response factor, its cofactors and the link to signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Epithelial cell-cell contacts regulate SRF-mediated transcription via Rac-actin-MAL signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Regulation of SRF activity by Rho family GTPases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Post-Translational Modification and Subcellular Distribution of Rac1: An Update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Protein Geranylgeranyltransferase Type 1 as a Target in Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

A palmitoylation switch mechanism regulates Rac1 function and membrane organization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Monitoring the cellular effects of HMG-CoA reductase inhibitors in vitro and ex vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Simvastatin reduces MMP1 expression in human smooth muscle cells cultured on polymerized collagen by inhibiting Rac1 activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Inhibition of Ras for cancer treatment: the search continues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Prenyltransferase Inhibitors: Treating Human Ailments from Cancer to Parasitic Infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Geranylgeranyltransferase type I (GGTase-I) deficiency hyperactivates macrophages and induces erosive arthritis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Simvastatin stimulates apoptosis in cholangiocarcinoma by inhibition of Rac1 activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Palmitoyl acyltransferase assays and inhibitors (Review).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Rational design and characterization of a Rac GTPase-specific small molecule inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Critical off-target effects of the widely used Rac1 inhibitors NSC23766 and EHT1864 in mouse platelets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

NSC23766, a widely used inhibitor of Rac1 activation, additionally acts as a competitive antagonist at muscarinic acetylcholine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Rac1 in human diseases: The therapeutic potential of targeting Rac1 signaling regulatory mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

The Rac Inhibitor EHop-016 Inhibits Mammary Tumor Growth and Metastasis in a Nude Mouse Model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Specificity and mechanism of action of EHT 1864, a novel small molecule inhibitor of Rac family small GTPases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

The evolutionary history of effectors downstream of Cdc42 and Rac.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Chemically Diverse Group I p21-Activated Kinase (PAK) Inhibitors Impart Acute Cardiovascular Toxicity with a Narrow Therapeutic Window

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Optimization of a Dibenzodiazepine Hit to a Potent and Selective Allosteric PAK1 Inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

RAS and RHO families of GTPases directly regulate distinct phosphoinositide 3-kinase isoforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Targeting effector pathways in RAC1P29S-driven malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Identification of Pirin as a Molecular Target of the CCG-1423/CCG-203971 Series of Antifibrotic and Antimetastatic Compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Pirin inhibits cellular senescence in melanocytic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

A small-molecule inhibitor shows that pirin regulates migration of melanoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Pirin delocalization in melanoma progression identified by high content immuno-detection based approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Demonstrating In-Cell Target Engagement Using a Pirin Protein Degradation Probe (CCT367766).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021

Gain-of-Function RHOA Mutations Promote Focal Adhesion Kinase Activation and Dependency in Diffuse Gastric Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRECAN.2020.02.021